Alejandro Benjamin Balazs, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Neutralizing | 28 | 2024 | 1935 | 2.960 |
Why?
|
Dependovirus | 13 | 2022 | 712 | 1.740 |
Why?
|
HIV Antibodies | 9 | 2023 | 1301 | 1.690 |
Why?
|
Antibodies, Viral | 21 | 2024 | 3149 | 1.390 |
Why?
|
Immunization, Passive | 6 | 2021 | 617 | 1.390 |
Why?
|
Genetic Vectors | 12 | 2021 | 3388 | 1.190 |
Why?
|
HIV Infections | 18 | 2024 | 17349 | 1.050 |
Why?
|
Gene Transfer Techniques | 7 | 2019 | 1201 | 1.010 |
Why?
|
HIV | 4 | 2024 | 1581 | 0.930 |
Why?
|
HIV-1 | 13 | 2024 | 6851 | 0.900 |
Why?
|
Smallpox Vaccine | 1 | 2024 | 77 | 0.880 |
Why?
|
AIDS Vaccines | 5 | 2022 | 891 | 0.800 |
Why?
|
Viral Vaccines | 2 | 2024 | 593 | 0.760 |
Why?
|
Immunity, Humoral | 3 | 2021 | 598 | 0.670 |
Why?
|
Antibody Formation | 6 | 2024 | 1391 | 0.660 |
Why?
|
Immunoglobulin G | 8 | 2023 | 4538 | 0.660 |
Why?
|
Virus Replication | 2 | 2024 | 2426 | 0.590 |
Why?
|
Influenza Vaccines | 3 | 2022 | 767 | 0.480 |
Why?
|
Vagina | 2 | 2022 | 841 | 0.440 |
Why?
|
Immunization | 2 | 2014 | 1218 | 0.410 |
Why?
|
Nursing Homes | 8 | 2024 | 1083 | 0.340 |
Why?
|
Coronavirus | 2 | 2021 | 156 | 0.320 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2022 | 4372 | 0.290 |
Why?
|
Animals | 35 | 2024 | 168083 | 0.280 |
Why?
|
Hematopoietic Stem Cells | 7 | 2023 | 3388 | 0.280 |
Why?
|
Influenza, Human | 2 | 2020 | 1521 | 0.270 |
Why?
|
Viral Envelope Proteins | 2 | 2022 | 639 | 0.270 |
Why?
|
Transgenes | 3 | 2019 | 1008 | 0.260 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3803 | 0.230 |
Why?
|
Monkeypox virus | 1 | 2024 | 43 | 0.230 |
Why?
|
Hemangioblasts | 1 | 2023 | 28 | 0.220 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2024 | 43 | 0.220 |
Why?
|
Neutralization Tests | 3 | 2021 | 725 | 0.220 |
Why?
|
Genetic Fitness | 1 | 2024 | 118 | 0.220 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1448 | 0.200 |
Why?
|
Mice | 24 | 2024 | 81324 | 0.200 |
Why?
|
Humans | 63 | 2024 | 761098 | 0.190 |
Why?
|
HEK293 Cells | 4 | 2021 | 4250 | 0.190 |
Why?
|
Primates | 1 | 2024 | 521 | 0.190 |
Why?
|
Vaccination | 5 | 2024 | 3368 | 0.190 |
Why?
|
High-Throughput Screening Assays | 2 | 2024 | 931 | 0.190 |
Why?
|
Antibodies, Monoclonal | 5 | 2023 | 9185 | 0.180 |
Why?
|
Glycoproteins | 2 | 2022 | 2203 | 0.180 |
Why?
|
Thoracic Neoplasms | 1 | 2023 | 268 | 0.180 |
Why?
|
Viral Tropism | 1 | 2021 | 101 | 0.180 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 302 | 0.180 |
Why?
|
Vaccines | 2 | 2021 | 835 | 0.170 |
Why?
|
Malaria, Falciparum | 2 | 2021 | 1076 | 0.170 |
Why?
|
Complement Activation | 1 | 2021 | 445 | 0.170 |
Why?
|
Immunotherapy | 1 | 2015 | 4642 | 0.170 |
Why?
|
Epitopes | 4 | 2022 | 2503 | 0.160 |
Why?
|
Vaccines, Synthetic | 4 | 2022 | 612 | 0.160 |
Why?
|
Disease Models, Animal | 7 | 2022 | 18217 | 0.160 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 2410 | 0.160 |
Why?
|
Herpes Simplex | 1 | 2022 | 465 | 0.160 |
Why?
|
Hematopoiesis | 2 | 2023 | 2046 | 0.160 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1527 | 0.160 |
Why?
|
Cross Reactions | 1 | 2020 | 818 | 0.160 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 410 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 800 | 0.150 |
Why?
|
Plasmodium falciparum | 2 | 2021 | 1740 | 0.150 |
Why?
|
SAIDS Vaccines | 1 | 2018 | 144 | 0.140 |
Why?
|
Immune Evasion | 1 | 2021 | 364 | 0.140 |
Why?
|
Cell Line | 6 | 2024 | 15542 | 0.140 |
Why?
|
Immunoglobulin A | 1 | 2020 | 978 | 0.140 |
Why?
|
Transduction, Genetic | 1 | 2019 | 900 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 43 | 0.130 |
Why?
|
Immunization, Secondary | 3 | 2024 | 366 | 0.130 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1822 | 0.130 |
Why?
|
Phagocytosis | 1 | 2021 | 1525 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1348 | 0.120 |
Why?
|
Mice, SCID | 3 | 2021 | 2621 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.120 |
Why?
|
Mutation | 4 | 2021 | 30006 | 0.120 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2016 | 267 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2022 | 4574 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2022 | 2150 | 0.110 |
Why?
|
CD4 Immunoadhesins | 1 | 2013 | 12 | 0.110 |
Why?
|
Lentivirus | 2 | 2020 | 507 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5478 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3582 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1027 | 0.110 |
Why?
|
Dendritic Cells | 2 | 2022 | 2726 | 0.110 |
Why?
|
Malaria Vaccines | 1 | 2014 | 163 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1837 | 0.100 |
Why?
|
Mice, Inbred BALB C | 3 | 2022 | 6198 | 0.100 |
Why?
|
Muscle Cells | 1 | 2013 | 195 | 0.100 |
Why?
|
Receptors, CCR5 | 1 | 2014 | 487 | 0.100 |
Why?
|
Protein Engineering | 1 | 2015 | 548 | 0.100 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 369 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3210 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6857 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5667 | 0.090 |
Why?
|
Interleukin-7 | 1 | 2010 | 143 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 8000 | 0.090 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2013 | 447 | 0.080 |
Why?
|
Neoplasms | 3 | 2022 | 22125 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4744 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2023 | 12743 | 0.080 |
Why?
|
Survival Analysis | 1 | 2020 | 10083 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3754 | 0.070 |
Why?
|
Macaca mulatta | 3 | 2021 | 2328 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8836 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2022 | 989 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2016 | 873 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2016 | 2197 | 0.070 |
Why?
|
Genetic Engineering | 1 | 2013 | 929 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22129 | 0.070 |
Why?
|
Antibodies, Protozoan | 2 | 2021 | 251 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4111 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2014 | 1027 | 0.070 |
Why?
|
Bone Marrow Diseases | 1 | 2008 | 233 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10514 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8663 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7386 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2010 | 974 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 2569 | 0.060 |
Why?
|
Female | 13 | 2024 | 392458 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2021 | 64670 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5413 | 0.060 |
Why?
|
Health Personnel | 3 | 2023 | 3335 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 709 | 0.060 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 249 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1761 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2023 | 63 | 0.050 |
Why?
|
Vaccines, Combined | 1 | 2023 | 70 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15845 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3094 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3216 | 0.050 |
Why?
|
Rhode Island | 1 | 2023 | 351 | 0.050 |
Why?
|
Ohio | 1 | 2023 | 322 | 0.050 |
Why?
|
Viral Load | 3 | 2022 | 3328 | 0.050 |
Why?
|
HIV Core Protein p24 | 1 | 2022 | 244 | 0.050 |
Why?
|
Poly I-C | 1 | 2022 | 112 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2011 | 1784 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
Endothelium | 1 | 2023 | 763 | 0.050 |
Why?
|
Gene Expression | 3 | 2016 | 7567 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 39953 | 0.040 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2023 | 420 | 0.040 |
Why?
|
Containment of Biohazards | 1 | 2020 | 37 | 0.040 |
Why?
|
Lymphoid Tissue | 1 | 2022 | 444 | 0.040 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2020 | 26 | 0.040 |
Why?
|
Vero Cells | 1 | 2021 | 482 | 0.040 |
Why?
|
Tropism | 1 | 2019 | 44 | 0.040 |
Why?
|
Lactation | 1 | 2022 | 397 | 0.040 |
Why?
|
Toll-Like Receptor 7 | 1 | 2020 | 165 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1667 | 0.040 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2021 | 355 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 261 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.040 |
Why?
|
Graft Survival | 2 | 2010 | 3841 | 0.040 |
Why?
|
HIV Antigens | 1 | 2020 | 325 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 536 | 0.040 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 282 | 0.040 |
Why?
|
Male | 8 | 2024 | 360675 | 0.040 |
Why?
|
Antigens, Ly | 1 | 2019 | 294 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 328 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13382 | 0.040 |
Why?
|
Doxorubicin | 1 | 1985 | 2224 | 0.040 |
Why?
|
Viremia | 1 | 2021 | 707 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9518 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2021 | 1681 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1553 | 0.040 |
Why?
|
Plasma Cells | 1 | 2020 | 597 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 577 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1750 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2022 | 2666 | 0.030 |
Why?
|
Hydrocortisone | 1 | 1985 | 1818 | 0.030 |
Why?
|
Adult | 5 | 2023 | 221083 | 0.030 |
Why?
|
Plasma | 1 | 2020 | 586 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2023 | 1891 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 988 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2022 | 858 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1737 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2802 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 996 | 0.030 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2016 | 63 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1843 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2135 | 0.030 |
Why?
|
Biological Evolution | 1 | 2021 | 1075 | 0.030 |
Why?
|
Middle Aged | 4 | 2022 | 220835 | 0.030 |
Why?
|
Protozoan Proteins | 1 | 2021 | 846 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2023 | 11505 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2415 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 541 | 0.030 |
Why?
|
MicroRNAs | 1 | 2010 | 3758 | 0.030 |
Why?
|
Sporozoites | 1 | 2014 | 82 | 0.030 |
Why?
|
Plasmodium berghei | 1 | 2014 | 159 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 2018 | 810 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1014 | 0.030 |
Why?
|
Aged | 5 | 2024 | 169266 | 0.030 |
Why?
|
United States | 3 | 2022 | 72337 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1709 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10203 | 0.030 |
Why?
|
Cyclosporine | 1 | 2015 | 776 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2022 | 26187 | 0.020 |
Why?
|
Spleen | 2 | 2010 | 2290 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2016 | 10421 | 0.020 |
Why?
|
DNA Primers | 1 | 2015 | 2815 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29872 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7189 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3048 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3696 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3044 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 18926 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5249 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1985 | 3609 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4565 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2010 | 781 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2926 | 0.020 |
Why?
|
Hepatocytes | 1 | 2014 | 1231 | 0.020 |
Why?
|
Hepacivirus | 1 | 2014 | 1330 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2816 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2010 | 693 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2455 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5754 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54419 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2547 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2864 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1831 | 0.020 |
Why?
|
Drug Resistance, Viral | 1 | 2011 | 862 | 0.020 |
Why?
|
Liver | 1 | 2022 | 7513 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10755 | 0.020 |
Why?
|
Adenine | 1 | 2011 | 986 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23415 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14676 | 0.020 |
Why?
|
Sepharose | 1 | 1985 | 102 | 0.020 |
Why?
|
Tissue Extracts | 1 | 1985 | 139 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5775 | 0.010 |
Why?
|
Bone Marrow | 2 | 2004 | 2911 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6565 | 0.010 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 609 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 260 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1404 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13404 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9979 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 3026 | 0.010 |
Why?
|
Gamma Rays | 1 | 2004 | 318 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22157 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8701 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7844 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17598 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4189 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2010 | 11856 | 0.010 |
Why?
|
Microtubules | 1 | 2008 | 1071 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20120 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3269 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4386 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10758 | 0.010 |
Why?
|
Drug Synergism | 1 | 1985 | 1756 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9435 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12983 | 0.010 |
Why?
|
Homeostasis | 1 | 2010 | 3318 | 0.010 |
Why?
|
Cattle | 1 | 1985 | 3819 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58946 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3409 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41486 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4510 | 0.010 |
Why?
|
Cell Division | 1 | 1985 | 4451 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2692 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9300 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9455 | 0.010 |
Why?
|
Child | 1 | 2022 | 80134 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59199 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3700 | 0.010 |
Why?
|
Proteins | 1 | 2008 | 5993 | 0.010 |
Why?
|
Brain | 1 | 2019 | 27097 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 3763 | 0.010 |
Why?
|